236 related articles for article (PubMed ID: 32808236)
1. Prognostic Factors of Long-term Survival Following Radical Resection for Ampullary Carcinoma.
Vilhordo DW; Gregório C; Valentini DF; Edelweiss MIA; Uchoa DM; Osvaldt AB
J Gastrointest Cancer; 2021 Sep; 52(3):872-881. PubMed ID: 32808236
[TBL] [Abstract][Full Text] [Related]
2. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
[No Abstract] [Full Text] [Related]
3. Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer.
Yun SP; Seo HI
BMC Gastroenterol; 2015 Nov; 15():165. PubMed ID: 26603157
[TBL] [Abstract][Full Text] [Related]
4. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
[TBL] [Abstract][Full Text] [Related]
5. Lymph node involvement and not the histophatologic subtype is correlated with outcome after resection of adenocarcinoma of the ampulla of vater.
de Paiva Haddad LB; Patzina RA; Penteado S; Montagnini AL; da Cunha JE; Machado MC; Jukemura J
J Gastrointest Surg; 2010 Apr; 14(4):719-28. PubMed ID: 20107918
[TBL] [Abstract][Full Text] [Related]
6. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
Falconi M; Crippa S; Domínguez I; Barugola G; Capelli P; Marcucci S; Beghelli S; Scarpa A; Bassi C; Pederzoli P
Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
[TBL] [Abstract][Full Text] [Related]
7. The role of lymph nodes in predicting the prognosis of ampullary carcinoma after curative resection.
Chen SC; Shyr YM; Chou SC; Wang SE
World J Surg Oncol; 2015 Jul; 13():224. PubMed ID: 26205252
[TBL] [Abstract][Full Text] [Related]
8. Prognostic relevance of lymph node status for patients with ampullary adenocarcinoma after radical resection followed by adjuvant treatment.
Kwon J; Kim K; Chie EK; Kim BH; Jang JY; Kim SW; Oh DY; Bang YJ
Eur J Surg Oncol; 2017 Sep; 43(9):1690-1696. PubMed ID: 28648977
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic factors in adenocarcinoma of the ampulla of Vater].
Fernández Aceñero MJ; Martínez Useros J; Díez-Valladares L; Ortega-Medina L; Pérez Aguirre E; de la Serna Esteban S; García Botella S; Díaz Del Arco C
Rev Esp Patol; 2018; 51(4):210-215. PubMed ID: 30269771
[TBL] [Abstract][Full Text] [Related]
10. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
[TBL] [Abstract][Full Text] [Related]
11. Determining the Adequate Examined Lymph Node Count in Resected Ampullary Adenocarcinoma-A National Cohort Study.
Nassour I; Christie A; Choti MA; Mansour JC; Minter RM; Polanco PM; Augustine MM; Porembka MR; Xie XJ; Wang SC
J Gastrointest Surg; 2018 May; 22(5):792-801. PubMed ID: 29546687
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis.
Winter JM; Cameron JL; Olino K; Herman JM; de Jong MC; Hruban RH; Wolfgang CL; Eckhauser F; Edil BH; Choti MA; Schulick RD; Pawlik TM
J Gastrointest Surg; 2010 Feb; 14(2):379-87. PubMed ID: 19911239
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.
Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG
J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival.
Morini S; Perrone G; Borzomati D; Vincenzi B; Rabitti C; Righi D; Castri F; Manazza AD; Santini D; Tonini G; Coppola R; Onetti Muda A
Pancreas; 2013 Jan; 42(1):60-6. PubMed ID: 22889982
[TBL] [Abstract][Full Text] [Related]
15. Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater.
Todoroki T; Koike N; Morishita Y; Kawamoto T; Ohkohchi N; Shoda J; Fukuda Y; Takahashi H
Ann Surg Oncol; 2003 Dec; 10(10):1176-83. PubMed ID: 14654474
[TBL] [Abstract][Full Text] [Related]
16. Pattern analysis of lymph node metastasis and the prognostic importance of number of metastatic nodes in ampullary adenocarcinoma.
Lee JH; Lee KG; Ha TK; Jun YJ; Paik SS; Park HK; Lee KS
Am Surg; 2011 Mar; 77(3):322-9. PubMed ID: 21375845
[TBL] [Abstract][Full Text] [Related]
17. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
[TBL] [Abstract][Full Text] [Related]
18. Very early recurrence following pancreaticoduodenectomy in patients with ampullary cancer.
Park HM; Park SJ; Han SS; Hong SK; Hong EK; Kim SW
Medicine (Baltimore); 2019 Nov; 98(44):e17711. PubMed ID: 31689805
[TBL] [Abstract][Full Text] [Related]
19. Adenocarcinoma of the ampulla of Vater: T-stage, chromosome 17p allelic loss, and extended pancreaticoduodenectomy are relevant prognostic factors.
Iacono C; Verlato G; Zamboni G; Scarpa A; Montresor E; Capelli P; Bortolasi L; Serio G
J Gastrointest Surg; 2007 May; 11(5):578-88. PubMed ID: 17468917
[TBL] [Abstract][Full Text] [Related]
20. Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater.
Chang DK; Jamieson NB; Johns AL; Scarlett CJ; Pajic M; Chou A; Pinese M; Humphris JL; Jones MD; Toon C; Nagrial AM; Chantrill LA; Chin VT; Pinho AV; Rooman I; Cowley MJ; Wu J; Mead RS; Colvin EK; Samra JS; Corbo V; Bassi C; Falconi M; Lawlor RT; Crippa S; Sperandio N; Bersani S; Dickson EJ; Mohamed MA; Oien KA; Foulis AK; Musgrove EA; Sutherland RL; Kench JG; Carter CR; Gill AJ; Scarpa A; McKay CJ; Biankin AV
J Clin Oncol; 2013 Apr; 31(10):1348-56. PubMed ID: 23439753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]